featured
Surgery vs 5% Imiquimod for Nodular and Superficial Basal Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Investigative Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Surgery Versus 5% Imiquimod for Nodular and Superficial Basal Cell Carcinoma: 5-Year Results of the SINS Randomized Controlled Trial
J Invest Dermatol 2016 Nov 23;[EPub Ahead of Print], HC Williams, F Bath-Hextall, M Ozolins, SJ Armstrong, GB Colver, W Perkins, PS Miller,From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.